Norges Bank Novan, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$7.48 - $10.17 $448,800 - $610,200
-60,000 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$7.8 - $17.35 $468,000 - $1.04 Million
60,000 New
60,000 $604,000

About Novan, Inc.

NOVN Quotes by TradingView
  • Ticker NOVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,281,600
  • Market Cap $638K
  • Description
  • Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...
More about NOVN
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email